Ceribell (CBLL) Short-term Investments (2025 - 2026)
Ceribell (CBLL) reported Short-term Investments of $95.9 million for Q1 2026, up 226.97% on a YoY basis from $29.3 million in Q1 2025, and down 19.24% quarter-over-quarter from $118.8 million in Q4 2025.
Ceribell (CBLL) Short-term Investments (2025 - 2026) Analysis & Trends
Ceribell has reported Short-term Investments for 2 years, with the latest figure at $95.9 million in Q1 2026.
- For the quarter ending Q1 2026, Short-term Investments rose 226.97% year-over-year to $95.9 million; the trailing twelve-month figure through Mar 2026 stood at $95.9 million (up 226.97% YoY), and the FY2025 full-year result was $118.8 million, changed N/A from the prior year.
- Short-term Investments for Q1 2026 stood at $95.9 million, down from $118.8 million in the prior quarter.
- The five-year high for Short-term Investments was $144.8 million in Q3 2025, with the low at $29.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Ceribell | 679.82 Mn | 538.64 Mn | 23.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 95.93 Mn |
| Dec 31, 2025 | 118.79 Mn |
| Sep 30, 2025 | 144.80 Mn |
| Jun 30, 2025 | 137.29 Mn |
| Mar 31, 2025 | 29.34 Mn |